ALDEHYDE DEHYDROGENASE, ALDOSE REDUCTASE, AND FREE-RADICAL SCAVENGERS IN CATARACT

被引:15
作者
CRABBE, MJC [1 ]
HOE, ST [1 ]
机构
[1] UNIV OXFORD,NUFFIELD LAB OPHTHALMOL,OXFORD,ENGLAND
关键词
BENDAZAC; STEROIDS; CYANATE; ASPIRIN; ALDEHYDE DEHYDROGENASE; ALDOSE REDUCTASE; CATARACT;
D O I
10.1159/000468888
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human lens was found to contain aldehyde dehydrogenase at a level of activity similar to that of bovine lens, namely 1.76 +/- 0.51 IU/g. The enzyme, which appears to be a tetramer of 229 kD, was less susceptible to inhibition by cataractogenic agents than the bovine enzyme. The lipid peroxidation product malondialdehyde was a good substrate of the human lens enzyme. The in vitro aldose reductase reaction, which we have shown is caused by glyceraldehyde-stimulated free-radical NADPH oxidation, is inhibited by the potential anti-cataract agents, bendazac acid and bendazac lysine; these compounds also inhibit ferricytochrome c reduction in the presence of DL-glyceraldehyde and scavenge superoxide radicals. These results are consistent with the hypotheses that aldehyde dehydrogenase is a protective enzyme in the human lens, and that the peroxy radical scavenging effects of bendazac acid and bendazac lysine contribute to their anti-cataract activity.
引用
收藏
页码:188 / 193
页数:6
相关论文
共 20 条
[1]  
COMPTON M, 1985, EXP EYE RES, V40, P297
[2]   ALDOSE REDUCTASE INHIBITORS AND CATARACT [J].
CRABBE, MJC .
INTERNATIONAL OPHTHALMOLOGY, 1991, 15 (01) :25-36
[3]  
CRABBE MJC, 1982, ENZYMOLOGY CARBONYL, P329
[4]  
Harding J., 1991, CATARACT BIOCH EPIDE
[5]  
HARDING JJ, 1984, EYE B, V1, P207
[6]   KINETIC EFFECTS OF METAL-ION CHELATING REAGENTS AND THEIR ANALOGS ON BOVINE LENS ALDEHYDE DEHYDROGENASE [J].
HOE, ST ;
CRABBE, MJC .
EXPERIMENTAL EYE RESEARCH, 1987, 44 (05) :663-675
[7]  
HOMES RS, 1986, EXP EYE RES, V43, P383
[8]   SPIROHYDANTOIN INHIBITORS OF ALDOSE REDUCTASE INHIBIT IRON-CATALYZED AND COPPER-CATALYZED ASCORBATE OXIDATION INVITRO [J].
JIANG, ZY ;
ZHOU, QL ;
EATON, JW ;
KOPPENOL, WH ;
HUNT, JV ;
WOLFF, SP .
BIOCHEMICAL PHARMACOLOGY, 1991, 42 (06) :1273-1278
[9]  
KINOSHITA JIN H., 1965, INVEST OPHTHALMOL, V4, P786
[10]   BENDAZAC PREVENTS CYANATE BINDING TO SOLUBLE LENS PROTEINS AND CYANATE-INDUCED PHASE-SEPARATION OPACITIES INVITRO - A POSSIBLE MECHANISM BY WHICH BENDAZAC COULD DELAY CATARACT [J].
LEWIS, BS ;
RIXON, KC ;
HARDING, JJ .
EXPERIMENTAL EYE RESEARCH, 1986, 43 (06) :973-979